It was previously demonstrated that overexpression of K18 in the ERα-negative and highly invasive MDA-MB-231 breast cancer cell line caused a marked reduction in the aggressiveness of the cells in vitro and in vivo but had no significant effect on cell growth rate. The gene discussed is ESR1; the disease is breast cancer.